Lumeda Inc

The International Society for Clinical Densitometry (ISCD) is a global organization dedicated to advancing the quality of musculoskeletal health assessments and treatments for practitioners around the world. With a focus on superior patient care, ISCD provides official positions, resources, and courses to enhance the knowledge and skills of clinicians and technologists in the field of bone densitometry. Through their online courses, including the Quality Bone Densitometry Clinicians Course and the Quality Bone Densitometry Technologists Course, ISCD offers continuing education opportunities for ACCME and ASRT credit. Additionally, ISCD hosts an annual meeting, symposiums, and provides access to a knowledge base, calculators, and DXA report examples to support practitioners in their musculoskeletal health assessments. As a trusted authority in the field, ISCD is committed to promoting best practices and ensuring the highest standards in bone densitometry.Generated from the website

RevMedica, Inc., based in Durham, CT, is an innovative MedTech company focused on transforming soft tissue management through cost-effective and environmentally friendly surgical systems. Founded in 2017, the company is committed to enhancing clinical decision-making and patient safety while fostering a sustainable operating room environment. With a team boasting extensive experience and a robust patent portfolio, RevMedica is led by industry veterans who have a track record of success in medical device commercialization. The company's cutting-edge technology and strategic vision aim to optimize surgical procedures and improve overall clinical outcomes. Generated from the website

BioXcel Therapeutics, Inc, situated in New Haven, CT, is at the forefront of innovation in the pharmaceutical industry. Utilizing an AI-based approach, the company focuses on re-innovating drug development to enhance research and development efficiencies. This cutting-edge methodology not only enables BioXcel Therapeutics to shorten development timelines but also significantly increases the probability of success in bringing novel treatments to market. Through their dedication to AI-driven drug re-innovation, the company strives to revolutionize patient care and improve healthcare outcomes. Generated from the website content